about
Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsUse of a recombinant strain of Mycobacterium avium expressing beta-galactosidase to evaluate the activities of antimycobacterial agents inside macrophagesBaAMPs: the database of biofilm-active antimicrobial peptides.Identification of novel proteins in culture filtrates of Mycobacterium bovis bacillus Calmette-Guérin in the isoelectric point range 6-11.Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosisThe ESX-5 associated eccB-EccC locus is essential for Mycobacterium tuberculosis viability.pH-dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25.Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis.Use of antimicrobial peptides against microbial biofilms: advantages and limits.Natural killer cells: a coherent model for their functional role in Mycobacterium tuberculosis infection.Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria.The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines.Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria.Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis.Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3.Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains.Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin.Expression of SA5K, a secretion antigen of Mycobacterium tuberculosis, inside human macrophages and in sputum from tuberculosis patients.Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis.Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluidsAnti-A and anti-B hemagglutinin depletion during Cohn purification process of 5% immunoglobulin.In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains.Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria.Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid.Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG.Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH.Three cases of human herpesvirus-6 latent infection: integration of viral genome in peripheral blood mononuclear cell DNA.Interaction between piroxicam and azithromycin during distribution to human periodontal tissues.Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium.Human herpesvirus 6 in non-AIDS related Hodgkin's and non-Hodgkin's lymphomas.Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium.Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2.In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia.Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation.Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates.Gammadelta+ and CD4+ alphabeta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts.Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guerin in human macrophages and in mice.Role of spore coats in the germinative response of Bacillus cereus to adenosine and its analogues.Chitosan Nanoparticles for the Linear Release of Model Cationic Peptide
P50
Q26991996-9D0731FA-7E7A-4A4B-924A-DB3FA50B8FB5Q28345265-E5E4CD62-240E-4996-8D52-DF080A8FFDC6Q30487708-3C307221-C53C-4B2D-B344-79D317824354Q33187021-5F8F0C41-8968-48C2-A1F6-2FF6AE7F4AE7Q33943565-877E245E-29E3-4CF1-8BE1-8012155DD89FQ34532886-6DAAC506-7CB6-4BFE-9C2A-233439682461Q34669079-0E04519B-EC4D-4539-A6BA-F59CE3C3756AQ35124624-9C9401BA-91C4-49FE-BCA2-B4F390DA197AQ37812624-F0E268FD-4BBA-4E36-80A8-F12DEE986418Q38246728-E3E38280-8462-4303-A810-4EEA99668A9BQ38622715-A7780F53-BB4D-4A8C-9D77-5771546923F7Q39777469-27D6C050-1434-4139-9F7C-0C74C5E42AD0Q39913256-092C1F70-AF83-4944-BE80-9E1EA78FE529Q40007773-D2A5F23F-4B01-4105-BC92-ED38F0E5E457Q40149176-CB7CD6F3-92DA-4EE4-A212-219D79B00370Q40161433-816D2D46-91AA-4F65-B23F-240CAB261509Q40346198-51C00A4E-D426-484E-8981-4B725C2B2A1DQ40564843-C70DCFA1-6F48-4219-90F6-EE675FEA34A8Q40627040-B34AC455-71DE-4EA2-96E1-E075BFAEA646Q40765753-1679CC68-4842-43A3-B7D9-AB6609CA638CQ41093148-1E33F329-BEE0-4EBC-B2DC-CCD3E25CDA04Q41108151-424F6521-70CC-44F0-A6F6-AEA71352450DQ41861374-A3D2BC14-0730-4A80-A59E-C29451972305Q42085198-AD1DA335-877F-46DB-BFE5-FBBE6901157FQ42573057-47D06A09-16B8-4D46-B1D1-034198CC845CQ42683869-7F7152D1-1F26-4549-A3D1-526C8CA319A8Q42936287-A9701FA0-3F6E-4971-B93D-0B04FC971070Q43450985-2C561DA1-63FB-48BC-A243-DF644B07919CQ43751462-5A1FBC8E-26BC-4EBD-9A0C-881F8354687CQ43787994-D721DE70-5864-46D6-816C-7985A12AD5E3Q43857519-64E6FDE9-9C37-42D4-ACE9-8E84F2078082Q43858205-8752A911-C47C-495F-96BE-44CC98BB04EFQ45901531-552ABF8F-BC76-43F3-B4E1-25B52C6723EBQ45972661-6D3E1449-E479-45D4-BAC9-E6FDD5777D12Q46837987-10A705D9-4C82-4B04-8E8E-B54BF8A0E92AQ51317435-9C615183-D716-4132-BF86-FDAD7CE6C3D5Q52530490-EF8FC6D6-DF65-4C64-8584-D35553B4BD09Q52563547-CF71FD01-6DDE-4CF4-8606-B8C27FD8B3F1Q54278656-2FBF2A41-0006-4745-A587-833C20B692F5Q59584747-D7466586-C245-44F4-A2E7-467D57541A5B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giovanna Batoni
@ast
Giovanna Batoni
@en
Giovanna Batoni
@es
Giovanna Batoni
@nl
Giovanna Batoni
@sl
type
label
Giovanna Batoni
@ast
Giovanna Batoni
@en
Giovanna Batoni
@es
Giovanna Batoni
@nl
Giovanna Batoni
@sl
prefLabel
Giovanna Batoni
@ast
Giovanna Batoni
@en
Giovanna Batoni
@es
Giovanna Batoni
@nl
Giovanna Batoni
@sl
P106
P21
P31
P496
0000-0002-4448-2385